52.4 F
New York
Monday, November 28, 2022

Date:

Share:

Owen Mumford Achieves B Corp Certification

Related Articles

ClinicalPURSUIT Offers Free Demonstration to Help Clinical Research Understand Their System and How It Can Help During Clinical Trials

Clayton, MO, November 25, 2022 --(PR.com)-- Clinical trials are expensive to conduct but are also essential in modern medicinal and therapeutic development. There is a...

ClinicalPURSUIT’s Software Offers Interactive Randomization Technology and RTSM to Help Researchers Conduct Flawless Clinical Research

Clayton, MO, November 25, 2022 --(PR.com)-- Clinical trials are crucial to developing modern medicines and therapeutic treatments. These research and trials are expected to be...

ClinicalPURSUIT’s Configurable Dashboards Assists Researchers in Conducting Clinical Research

Clayton, MO, November 25, 2022 --(PR.com)-- Clinical trials are fundamental to the success of modern medicinal and therapeutic development. However, there is a great need...

UK medical device leader obtains certified commitment to social and environmental performance, accountability and transparency

WOODSTOCK – OXFORDSHIRE, England, 12th July 2021 – Owen Mumford, a global leader in the design, manufacture and advancement of medical devices, today announced it has been awarded B Corp certification after demonstrating strict compliance to the rigorous requirements of this hard-to-achieve, globally-recognised mark. Owen Mumford, which established its sustainability programme in 2014 and has formally committed to the UN’s Sustainable Development Goals (SDGs), now joins a highly respected community of for-profit businesses that are applying growth and profit to the positive gain of the environment and external communities, as well as employees.

Jarl Severn

B Corp is the standard for a new generation of aspirational brands who are helping to define the future of business in a responsible way. There are now…

Read more…

Popular Articles